BPC-157/TB-500 20mg Specifications BB20 10mg/10mg 137525-51-0 / 77591-33-4 1419.54 / 4963.5 g/mol C62H98N16O22 / C212H350N56O78S Blend / Research Component-specific
Current laboratory research may include: Multi-receptor signalling investigations GLP-1, GIP, and glucagon receptor pathway studies Peptide interaction modelling Cellular signalling research Extracellular matrix investigations Peptide stability assessments Molecular structure analysis Cellular migration research Tissue-related laboratory models Comparative peptide research Advanced biological pathway modelling These applications are conducted exclusively within controlled laboratory settings by qualified research professionals
This entry excludes any dosing, injection frequency, or cycle-length information
Symptoms of deficiency include fatigue, weakness, neurological problems (such as paraesthesia, balance difficulties, and cognitive impairment), and megaloblastic anaemia
The benzyl alcohol component is effective in limiting microbial growth, but concentrations are kept low (0.9%) to avoid altering compound stability under research conditions
DAC (Drug Affinity Complex) binds to albumin in the bloodstream, which dramatically extends the peptide's half-life